SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Gladman, D D
Right arrow Articles by Farewell, V T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gladman, D D
Right arrow Articles by Farewell, V T
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Lost-to-follow-up study in systemic lupus erythematosus (SLE)

D D Gladman

The Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital, University Health Network, 399 Bathurst Street, MP-1-318, Toronto, Ontario, M5T 2S8 Canada

D-R Koh

M B Urowitz

The Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada

V T Farewell

The Department of Statistical Science, University College London, England

Objective: To determine the extent of and reasons for lost-to-follow-up, as well as its impact on outcome studies in a cohort of lupus patients.

Methods: As of September 1991, 247 patients, in a cohort of 621 patients with SLE, being followed in a long-term prognosis study, had not been seen since 1 March, 1990 and were considered lost-to-follow-up. Patients were contacted and encouraged to return for an evaluation or to answer a questionnaire by telephone. Descriptive statistics were used to compare the lost-to-follow-up and non-lost-to-follow-up patients and the survival experience during the lost-to-follow-up period was compared with that when patients were not considered lost-to-follow-up. Estimated survival curves with and without the information gained through contacts with lost-to-follow-up patients were compared.

Results: Of the 247 patients, 29 have died, 66 returned for a full assessment, 84 completed a questionnaire and 68 (11%) were true lost-to-follow-up. The lost-to-follow-up patient group had 10% more Caucasians and 6% more males than the patients under regular follow-up. The estimated survival curves of the entire cohort with and without the new lost-to-follow-up data, calculated as of July 1992, were very similar. There was no evidence of a differential mortality rate during the period in which patients were lost-to-follow-up. Some suggestive evidence that the relative mortality rate comparing the rate during a period of lost-to-follow-up and during a period of active follow-up may depend on disease duration at the time of lost-to-follow-up was found.

Conclusions: While it would be prudent to limit lost-to-follow-up as much as possible, especially for outcomes such as mortality which do not necessarily require a clinic visit, it does not appear that significant bias will be present in prospective studies based on our single clinic database. Since the retrieved 179 lost-to-follow-up patients did not affect survival studies it is likely that the 68 true lost-to-follow-up patients will also not have an impact on prognostic studies.

Key Words: SLE lost-to-follow-up

Lupus, Vol. 9, No. 5, 363-367 (2000)
DOI: 10.1191/096120300678828325


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Ann Rheum DisHome page
N. Costedoat-Chalumeau, Z. Amoura, J.-S. Hulot, G. Aymard, G. Leroux, D. Marra, P. Lechat, and J.-C. Piette
Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus
Ann Rheum Dis, June 1, 2007; 66(6): 821 - 824.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
A M Bertoli, M Fernandez, J Calvo-Alen, L M Vila, M L Sanchez, J D Reveille, G S Alarcon, and LUMINA Study Group
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XXXI: factors associated with patients being lost to follow-up
Lupus, January 1, 2006; 15(1): 19 - 25.
[Abstract] [PDF]


Home page
LupusHome page
A G Uribe, K T Ho, B Agee, G McGwin Jr, B J Fessler, H M Bastian, J D Reveille, and G S Alarcon
Relationship between adherence to study and clinic visits in systemic lupus erythematosus patients: data from the LUMINA cohort
Lupus, August 1, 2004; 13(8): 561 - 568.
[Abstract] [PDF]


Home page
LupusHome page
A Zink, R Fischer-Betz, K Thiele, J Listing, D Huscher, E Gromnica-Ihle, C Specker, M Schneider, and German Collaborative Arthritis Centres
Health care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the national database of the German Collaborative Arthritis Centres
Lupus, July 1, 2004; 13(7): 529 - 536.
[Abstract] [PDF]



Advertisement